Literature DB >> 21664420

Melanocortin 4 receptor is a transcriptional target of nescient helix-loop-helix-2.

Umesh D Wankhade1, Deborah J Good.   

Abstract

Melanocortin 4 receptor (Mc4r/MC4R) is a G-Protein coupled receptor that is expressed in the hypothalamus and implicated in body weight control. Mutations in MC4R are the most frequent cause of monogenetic forms of human obesity. Despite its importance, the MC4R signaling pathways and transcriptional regulation underlying the melanocortin pathway are far from being fully understood. The transcription factor nescient helix-loop-helix 2 (Nhlh2) influences the melanocortin pathway through transcriptional regulation of prohormone convertase I, which influences the production of melanocortin peptides. In the present study, Nhlh2's role as a transcriptional regulator of Mc4r has been demonstrated. Nhlh2 knockout mice have reduced hypothalamic expression of Mc4r mRNA, suggesting that it could be a direct or indirect transcriptional regulator of the Mc4r promoter. To demonstrate direct transcriptional regulation, chromatin immunoprecipitation and electrophoretic gel shift assays show that Nhlh2 binds to the E-Boxes located at -551, -366 and +54 on the Mc4r promoter. Leptin-induced transactivation of the Mc4r promoter is significantly higher in the presence of exogenously added Nhlh2. siRNA knockdown of Nhlh2 leads to significantly reduced endogenous Mc4r mRNA expression levels in N29/2 cell line. Transactivation using promoters with mutations in each of the E-Boxes results in significantly reduced transactivation efficiency compared to the WT Mc4r promoter, suggesting that Nhlh2 regulates Mc4r transcription through these sites. Findings from these studies, combined with previous work implicating Nhlh2 as a transcriptional regulator of both the Mc4r gene and the melanocortin pathway, suggest that Nhlh2's transcriptional activity directly influences the human and rodent body weight control pathways.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21664420      PMCID: PMC3143283          DOI: 10.1016/j.mce.2011.05.022

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  31 in total

Review 1.  Obesity as a medical problem.

Authors:  P G Kopelman
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

2.  Generation of a phenotypic array of hypothalamic neuronal cell models to study complex neuroendocrine disorders.

Authors:  Denise D Belsham; Fang Cai; Hong Cui; Simon R Smukler; Anne Marie F Salapatek; Lulzim Shkreta
Journal:  Endocrinology       Date:  2003-10-09       Impact factor: 4.736

3.  NSCL-1 and NSCL-2 synergistically determine the fate of GnRH-1 neurons and control necdin gene expression.

Authors:  Marcus Krüger; Karen Ruschke; Thomas Braun
Journal:  EMBO J       Date:  2004-10-07       Impact factor: 11.598

4.  Reduced voluntary activity precedes adult-onset obesity in Nhlh2 knockout mice.

Authors:  Christopher A Coyle; Enxuan Jing; Trina Hosmer; J Bradley Powers; George Wade; Deborah J Good
Journal:  Physiol Behav       Date:  2002-11

5.  Assignment of the human carboxypeptidase E (CPE) gene to chromosome 4.

Authors:  C Hall; E Manser; N K Spurr; L Lim
Journal:  Genomics       Date:  1993-02       Impact factor: 5.736

6.  The human MC4R promoter: characterization and role in obesity.

Authors:  Cecile Lubrano-Berthelier; Martha Cavazos; Catherine Le Stunff; Kurt Haas; Astrid Shapiro; Sumei Zhang; Pierre Bougneres; Christian Vaisse
Journal:  Diabetes       Date:  2003-12       Impact factor: 9.461

7.  Effect of androgen insensitivity on diabetogenesis in db/db male mice with testicular feminization (Tfm).

Authors:  M Prochazka; E H Leiter
Journal:  Horm Metab Res       Date:  1991-04       Impact factor: 2.936

8.  Deletion of the Nhlh2 transcription factor decreases the levels of the anorexigenic peptides alpha melanocyte-stimulating hormone and thyrotropin-releasing hormone and implicates prohormone convertases I and II in obesity.

Authors:  Enxuan Jing; Eduardo A Nillni; Vanesa C Sanchez; Ronald C Stuart; Deborah J Good
Journal:  Endocrinology       Date:  2003-12-30       Impact factor: 4.736

9.  Melanocortin 4 receptor sequence variations are seldom a cause of human obesity: the Swedish Obese Subjects, the HERITAGE Family Study, and a Memphis cohort.

Authors:  Peter Jacobson; Olavi Ukkola; Tuomo Rankinen; Eric E Snyder; Arthur S Leon; D C Rao; James S Skinner; Jack H Wilmore; Lars Lönn; George S Cowan; Lars Sjöström; Claude Bouchard
Journal:  J Clin Endocrinol Metab       Date:  2002-10       Impact factor: 5.958

10.  Deletion of Nhlh2 results in a defective torpor response and reduced Beta adrenergic receptor expression in adipose tissue.

Authors:  Umesh D Wankhade; Kristen R Vella; Dana L Fox; Deborah J Good
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

View more
  9 in total

Review 1.  Patterning, specification, and differentiation in the developing hypothalamus.

Authors:  Joseph L Bedont; Elizabeth A Newman; Seth Blackshaw
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-03-27       Impact factor: 5.814

2.  Two single nucleotide polymorphisms in the human nescient helix-loop-helix 2 (NHLH2) gene reduce mRNA stability and DNA binding.

Authors:  Numan Al Rayyan; Umesh D Wankhade; Korie Bush; Deborah J Good
Journal:  Gene       Date:  2012-09-28       Impact factor: 3.688

3.  Leptin signaling regulates hypothalamic expression of nescient helix-loop-helix 2 (Nhlh2) through signal transducer and activator 3 (Stat3).

Authors:  Numan Al Rayyan; Jinhua Zhang; Amy S Burnside; Deborah J Good
Journal:  Mol Cell Endocrinol       Date:  2014-01-29       Impact factor: 4.102

Review 4.  A molecular conundrum involving hypothalamic responses to and roles of long non-coding RNAs following food deprivation.

Authors:  Hao Jiang; Deborah J Good
Journal:  Mol Cell Endocrinol       Date:  2016-08-20       Impact factor: 4.102

5.  Arcuate Nucleus Overexpression of NHLH2 Reduces Body Mass and Attenuates Obesity-Associated Anxiety/Depression-like Behavior.

Authors:  Rodrigo S Carraro; Guilherme A Nogueira; Davi Sidarta-Oliveira; Rodrigo S Gaspar; Nathalia R Dragano; Joseane Morari; Vanessa C D Bobbo; Eliana P Araujo; Natalia F Mendes; Ariane M Zanesco; Natalia Tobar; Celso D Ramos; Jéssica M Toscaro; Marcio C Bajgelman; Licio A Velloso
Journal:  J Neurosci       Date:  2021-10-21       Impact factor: 6.709

6.  The atypical antipsychotic risperidone targets hypothalamic melanocortin 4 receptors to cause weight gain.

Authors:  Li Li; Eun-Seon Yoo; Xiujuan Li; Steven C Wyler; Xiameng Chen; Rong Wan; Amanda G Arnold; Shari G Birnbaum; Lin Jia; Jong-Woo Sohn; Chen Liu
Journal:  J Exp Med       Date:  2021-05-12       Impact factor: 14.307

7.  Inactivating NHLH2 variants cause idiopathic hypogonadotropic hypogonadism and obesity in humans.

Authors:  A Kemal Topaloglu; Enver Simsek; Matthew A Kocher; Jamala Mammadova; Ece Bober; Leman Damla Kotan; Ihsan Turan; Can Celiloglu; Fatih Gurbuz; Bilgin Yuksel; Deborah J Good
Journal:  Hum Genet       Date:  2022-01-23       Impact factor: 5.881

8.  DNA methylation in demyelinated multiple sclerosis hippocampus.

Authors:  Anthony M Chomyk; Christina Volsko; Ajai Tripathi; Sadie A Deckard; Bruce D Trapp; Robert J Fox; Ranjan Dutta
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

Review 9.  A new aspect of chronic pain as a lifestyle-related disease.

Authors:  Emiko Senba; Katsuya Kami
Journal:  Neurobiol Pain       Date:  2017-04-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.